We then assessed depression-like behavior using the forced-swim test (FST), cognition using the novel object-location and object-in-place tests, and alterations in hippocampal neurogenesis, reelin, and GABAA receptors using immunohistochemistry. The gene discussed is RELN; the disease is depressive symptom measurement.